J Korean Radiol Soc.
1995 Jan;32(1):71-76.
Treatment of Malignant Biliar Obstruction with Wallstent Endoprosthesis
Abstract
- PURPOSE
The purpose of this study was to evaluate the patency, procedure related complications and
effectiveness of Wallstent application to the malignant biliary obstruction as a palliative treatment.
MATERIALS AND METHODS
We retrospectively reviewed the clinical results, duration of survival, patency rate
and complication of the Wallstent application on 33 patients who had had obstructive jaundice by the malignant
lesion in recent 3 years. One or two step procedures. were mainly taken with 10mm diameter Wallstents.
Grouping according to place the stent at the hilum or not, and grouping according to place the stent through the
ampulla or not were done to evaluate the difference of the patency and survival rate between the groups.
RESULTS
Biliary endoprosthesis with Wallstent were successfully placed in all patients without difficulty.
Procedure related short-term complication rate was about 18.1% (n=6/33). Complications were fever(n=4),
cholecystitis(n=1) and sepsis(n=l). Long-term complications were mainly obstruction(n=9/31) of the Wallstent
during the follow-up period. Also cholecystitis occurred in one patient 3 months later. Mean survival duration
was 139.72 (46-237)days ormong those who expired. Mean patency duration of stents was 139.67 (26-310)
days. Survival rates were 93.5% at the second month, 68.8% at the third month, 61.2% at the 4th month, 53.5%
at the 5th month, 49.1% at the 7th month and 35.7% at the 9th month. Patency rates were 93.7% at the second
month, 84.2% at the 4th month, 66.9% at the 5th month, 59.5% at the 7th month and 39.6% at the 10th month.
The application was repeated in the 6 patients with stent occlusion. Significant statistical difference could not
be found between the groups according to placing the stent at the hilum and according to placing the stent
through the ampulla. Patency rates were higher than survival rates in the follow-up period.
CONCLUSION
Wallstent application provides good palliation with little discomfort and few complications in the
patients with malignant obstructive jaundice.